Results 171 to 180 of about 26,236 (223)

Host-interferon-stimulated gene response to virus-host recombinant variants of hepatitis E virus and enhanced viral replication. [PDF]

Microbiol Spectr
Paronetto O, Allioux C, Zahm M, Gonzalez AA, Jeanne N, Chaubet A, Collercandy N, Abravanel F, Lhuillier É, Chapuy-Regaud S, Izopet J, Lhomme S.   +11 more
europepmc   +1 more source

Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis. [PDF]

J Biochem Mol Toxicol
Valente LC, Silva JSD, Riechelmann-Casarin L, Romeiro FG, Barbisan LF, Romualdo GR.   +5 more
europepmc   +1 more source

Whole-genome evolutionary dynamics of human parainfluenza virus type 3 in Shanghai, China, 2016-2024. [PDF]

Virol Sin
Zhou Y, Wang X, Zhang L, Yuan Y, Liu T, Yang Y, Zheng Y, Zhao B.   +7 more
europepmc   +1 more source

Synthesis, crystal structure determination, Hirshfeld surface and crystal void analyses, inter-action energy calculations and energy frameworks of (3a<i>RS</i>,4<i>RS</i>,9a<i>RS</i>)-2-benzyl-3-oxo-2,3,3a,4,9,9a-hexa-hydro-1<i>H</i>-benzo[<i>f</i>]iso-indole-4-carb-oxy-lic acid. [PDF]

Acta Crystallogr E Crystallogr Commun
Alekseeva KA, Hökelek T, Khrustalev VN, Kolomeytsev MY, Pronina AA, Belay AN, Hasanov KI.   +6 more
europepmc   +1 more source

<i>Moss-derived</i> recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy. [PDF]

Front Immunol
Imanifard Z, Penati F, Padoa S, Dabrowska-Schlepp P, Bresin E, Peracchi T, Benigni A, Remuzzi G, Noris M, Donadelli R.   +9 more
europepmc   +1 more source

Activation of the C3a-C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction. [PDF]

Basic Res Cardiol
Vahldieck C, Löning S, Hamacher C, Fels B, Svensson T, Rudzewski B, Weil J, Kusche K.   +7 more
europepmc   +1 more source

Immune activation during liver machine perfusion is shaped by perfusate composition and is independent of the ischemic injury. [PDF]

Front Immunol
Færden IH, Bliksøen M, Schjalm C, Pettersen K, Liavåg OMIB, Majeed WM, Hagness M, Mollnes TE, Pischke SE.   +8 more
europepmc   +1 more source

{Bis[2-(pyridin-2-yl)eth-yl]amine}-dibromidocopper(II). [PDF]

IUCrdata
Bess Z, Oscar C, Bithi UH, Duenas Parapar D, Lowe WJ, Madzig F, Gultneh Y, Butcher RJ.   +7 more
europepmc   +1 more source